| Amphiphilic poly (l-amino acids)—new materials for drug delivery A Lalatsa, AG Schätzlein, M Mazza, TBH Le, IF Uchegbu Journal of Controlled Release 161 (2), 523-536, 2012 | 245 | 2012 |
| Technology‐enhanced learning in higher education: How to enhance student engagement through blended learning DR Serrano, MA Dea‐Ayuela, E Gonzalez‐Burgos, A Serrano‐Gil, ... European Journal of Education 54 (2), 273-286, 2019 | 227 | 2019 |
| Strategies to deliver peptide drugs to the brain A Lalatsa, AG Schatzlein, IF Uchegbu Molecular pharmaceutics 11 (4), 1081-1093, 2014 | 161 | 2014 |
| Transferosomes as nanocarriers for drugs across the skin: Quality by design from lab to industrial scale R Fernández-García, A Lalatsa, L Statts, F Bolás-Fernández, ... International journal of pharmaceutics 573, 118817, 2020 | 160 | 2020 |
| Delivery of peptides to the blood and brain after oral uptake of quaternary ammonium palmitoyl glycol chitosan nanoparticles A Lalatsa, NL Garrett, T Ferrarelli, J Moger, AG Schatzlein, IF Uchegbu Molecular pharmaceutics 9 (6), 1764-1774, 2012 | 123 | 2012 |
| Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles DR Serrano, A Lalatsa, MA Dea-Ayuela, PE Bilbao-Ramos, NL Garrett, ... Molecular pharmaceutics 12 (2), 420-431, 2015 | 121 | 2015 |
| A Prodrug Nanoparticle Approach for the Oral Delivery of a Hydrophilic Peptide, Leucine5-enkephalin, to the Brain A Lalatsa, V Lee, JP Malkinson, M Zloh, AG Schätzlein, IF Uchegbu Molecular pharmaceutics 9 (6), 1665-1680, 2012 | 109 | 2012 |
| Exploring uptake mechanisms of oral nanomedicines using multimodal nonlinear optical microscopy NL Garrett, A Lalatsa, I Uchegbu, A Schätzlein, J Moger Journal of biophotonics 5 (5‐6), 458-468, 2012 | 107 | 2012 |
| Label‐free imaging of polymeric nanomedicines using coherent anti‐stokes Raman scattering microscopy NL Garrett, A Lalatsa, D Begley, L Mihoreanu, IF Uchegbu, AG Schätzlein, ... Journal of Raman Spectroscopy 43 (5), 681-688, 2012 | 78 | 2012 |
| Fundamentals of pharmaceutical nanoscience IF Uchegbu, AG Schätzlein, WP Cheng, A Lalatsa Springer Science & Business Media, 2013 | 76 | 2013 |
| 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms S Ayyoubi, JR Cerda, R Fernández-García, P Knief, A Lalatsa, AM Healy, ... International Journal of Pharmaceutics 597, 120336, 2021 | 67 | 2021 |
| Nanoparticulate peptide delivery exclusively to the brain produces tolerance free analgesia L Godfrey, A Iannitelli, NL Garrett, J Moger, I Imbert, T King, F Porreca, ... Journal of controlled release 270, 135-144, 2018 | 66 | 2018 |
| Peptide self-assemblies for drug delivery D M Leite, E Barbu, G J Pilkington, A Lalatsa Current topics in medicinal chemistry 15 (22), 2277-2289, 2015 | 64 | 2015 |
| Personalised 3D printed medicines: Optimising material properties for successful passive diffusion loading of filaments for fused deposition modelling of solid dosage forms JR Cerda, T Arifi, S Ayyoubi, P Knief, MP Ballesteros, W Keeble, E Barbu, ... Pharmaceutics 12 (4), 345, 2020 | 63 | 2020 |
| Designing fast-dissolving orodispersible films of amphotericin B for oropharyngeal candidiasis DR Serrano, R Fernandez-Garcia, M Mele, AM Healy, A Lalatsa Pharmaceutics 11 (8), 369, 2019 | 47 | 2019 |
| Chitosan amphiphile coating of peptide nanofibres reduces liver uptake and delivers the peptide to the brain on intravenous administration A Lalatsa, AG Schätzlein, NL Garrett, J Moger, M Briggs, L Godfrey, ... Journal of Controlled Release 197, 87-96, 2015 | 46 | 2015 |
| Traction of 3D and 4D printing in the healthcare industry: from drug delivery and analysis to regenerative medicine K Osouli-Bostanabad, T Masalehdan, RMI Kapsa, A Quigley, A Lalatsa, ... ACS Biomaterials Science & Engineering 8 (7), 2764-2797, 2022 | 45 | 2022 |
| Lomustine nanoparticles enable both bone marrow sparing and high brain drug levels–a strategy for brain cancer treatments FA Fisusi, A Siew, KW Chooi, O Okubanjo, N Garrett, K Lalatsa, D Serrano, ... Pharmaceutical research 33, 1289-1303, 2016 | 45 | 2016 |
| Orally bioavailable and effective buparvaquone lipid-based nanomedicines for visceral leishmaniasis L Smith, DR Serrano, M Mauger, F Bolás-Fernández, MA Dea-Ayuela, ... Molecular pharmaceutics 15 (7), 2570-2583, 2018 | 44 | 2018 |
| 3D printing technologies in personalized medicine, nanomedicines, and biopharmaceuticals DR Serrano, A Kara, I Yuste, FC Luciano, B Ongoren, BJ Anaya, G Molina, ... Pharmaceutics 15 (2), 313, 2023 | 42 | 2023 |
